Adverse events after discontinuing medications in elderly outpatients.
about
Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugsManaging therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinenceDeprescription: The prescription metabolismA pilot randomized controlled trial of deprescribing.Managing medications in clinically complex elders: "There's got to be a happy medium".Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.Discontinuity of chronic medications in patients discharged from the intensive care unitPrescribing for seniors: it's a balancing act.Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.Drug discontinuation effects are part of the pharmacology of a drugImproving geriatric mental health nursing care: making a case for going beyond psychotropic medications.Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with MultimorbidityPrevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans.Patient safety in guideline-based decision support for hypertension management: ATHENA DSSThe utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population.Clinical pharmacology in the geriatric patient.Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.Medicare Part D plan generosity and medication use among dual-eligible nursing home residents.The expanding scope of pharmacists' practice: implications for physicians.Reducing fall risk while managing hypotension, pain, and poor sleep in an 83-year-old woman.Profile, cost and pattern of prescriptions for polymedicated patients in Catalonia, Spain.Estimating the information gap between emergency department records of community medication compared to on-line access to the community-based pharmacy recordsRevisiting medication use in a frail 93-year-old man experiencing possible adverse effectsSupporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.Reducing fall risk while managing pain and insomnia: Addressing polypharmacy in an 81-year-old womanIdentifying and reducing complications of outpatient medications.Polypharmacy and medication adherence: small steps on a long road.Clinical vignettes to help you deprescribe medications in elderly patients: Introduction to the polypharmacy case seriesReducing polypharmacy in the elderly: Cases to help you "rock the boat".Mental health for older adults and benzodiazpine use.Patient Safety in Guideline-Based Decision Support for Hypertension Management: ATHENA DSS.
P2860
Q26795403-2C3F5BC0-5EA8-41A9-BCED-67705E62BE2CQ27027072-A589EE78-4B2F-4096-B90F-24584FF44744Q28070294-6163F83C-1BDC-4A95-A52B-A9490C04658DQ33949251-E066F829-2729-4721-B0EB-5391E61F39F7Q34311242-EC9C2F36-0C84-4F35-8B44-2CAA9A2D10B1Q34418562-DC71FE22-F8FB-4568-94B1-ECD7260296E0Q34522113-4B57B5AD-AF57-4BE4-AD20-0A62BD356513Q34554391-5A1A1147-E02A-4073-AC25-B09268AC438BQ34558641-4BEB3162-196A-4F00-99A8-8E3123CE12B4Q34586084-C4868D13-703C-4B8E-BEFF-53E677E49B6FQ35058123-4DA59F35-910B-444B-B615-078A2C17419BQ35430065-897530A0-0D3D-4642-9AC7-4CBDC9CD3F98Q35611538-7DC70863-D236-44AF-9A96-B269D4525214Q35695252-229E422F-131B-4B2C-9B60-A0ABBC0E2F1CQ36112491-D51B72D6-8004-4F5B-B78B-E31C5F67100FQ36460221-E66DB7EA-12A1-4F6C-8316-DD9DB1EA5495Q36463186-9B247C95-5385-459F-AB36-5671D2F49764Q36830192-FB6A825C-7D81-49B5-9C25-986BA978DA26Q37087367-746F614D-6AAC-49C0-AB1D-007BC72C32CDQ37171080-5A6DE5A1-34CA-4BD0-8C98-4312F30EBCA1Q37207692-8FC6927C-09C9-4136-A38C-B2B6192A5606Q37387535-83F29197-19FD-410E-BE0E-3563D31D1090Q37392058-ACC9F41F-ECC6-44AA-9D96-8366A3CFBDD7Q37715388-BB367D90-7A18-40BF-91E1-E95198BC3CE2Q38572061-5A28BB98-741B-4896-AF4C-CDEDE600508CQ38648396-0306FA49-6587-473B-A283-16B695B0A5F0Q42094275-B2489635-B726-4724-B6B5-4FE3AE8D1F7BQ42346686-B6914945-D358-460D-BABD-7019F3AA7DB9Q42347505-8405E8DA-6E46-4645-80EA-89B3BD08401BQ42752264-93150370-02C3-4E47-BA67-EA18E26F30F1Q42965625-4765F73E-58E6-433F-B312-E22FEEB06820Q51924843-3D31B60E-9DFC-49F3-A3D1-39A6A8BF2D01Q55547107-F6DA66DD-60BC-4C76-BC56-7A5991B96AB8
P2860
Adverse events after discontinuing medications in elderly outpatients.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Adverse events after discontinuing medications in elderly outpatients.
@en
Adverse events after discontinuing medications in elderly outpatients.
@nl
type
label
Adverse events after discontinuing medications in elderly outpatients.
@en
Adverse events after discontinuing medications in elderly outpatients.
@nl
prefLabel
Adverse events after discontinuing medications in elderly outpatients.
@en
Adverse events after discontinuing medications in elderly outpatients.
@nl
P2093
P1476
Adverse events after discontinuing medications in elderly outpatients.
@en
P2093
Landsman PB
Schmader KE
Weinberger M
P304
P356
10.1001/ARCHINTE.157.19.2205
P407
P577
1997-10-01T00:00:00Z